These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3083786

  • 1. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K, Nakame Y, Horiuchi S, Kaneoya F, Kuroda T, Tanoiri A, Koizumi M, Takahashi M, Negishi T, Saitoh H.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract] [Full Text] [Related]

  • 2. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
    Takahashi Y, Yamamoto N, Deguchi T, Kuriyama M, Yoh M, Yasuda M, Nakano M, Kawada Y, Takeuchi T, Shinoda I.
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 5. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA, de la Peña JJ, Hidalgo L, Cisneros J, Jiménez de León J, Machuca J.
    Arch Esp Urol; 1986 Oct; 39(1):33-46. PubMed ID: 3707210
    [No Abstract] [Full Text] [Related]

  • 6. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR.
    Prog Clin Biol Res; 1988 Oct; 260():481-5. PubMed ID: 3283768
    [No Abstract] [Full Text] [Related]

  • 7. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
    Hashimoto H, Tokumitsu M, Morikawa M, Numata A, Yachiku S, Iuchi H, Yamauchi K.
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T, Washizuka M, Kihara K, Takahashi T, Sakata Y, Tai K, Nagayama T, Okada K, Kusuyama H, Ishii Y.
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb 20; 22(1):40-6. PubMed ID: 3611890
    [No Abstract] [Full Text] [Related]

  • 11. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F.
    Prog Clin Biol Res; 1988 Feb 20; 260():599-602. PubMed ID: 3362909
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy for advanced urothelial cancer.
    Yagoda A.
    Semin Urol; 1983 Feb 20; 1(1):60-74. PubMed ID: 6382528
    [No Abstract] [Full Text] [Related]

  • 13. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H, Odachi M, Kagawa S, Kurokawa K.
    Gan To Kagaku Ryoho; 1985 Sep 20; 12(9):1877-9. PubMed ID: 4041165
    [Abstract] [Full Text] [Related]

  • 14. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb 20; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 15. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G.
    Wien Klin Wochenschr; 1987 Jan 23; 99(2):54-7. PubMed ID: 3564487
    [Abstract] [Full Text] [Related]

  • 16. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
    Sánchez Romero JA, Ramírez Ruiz F, Romero Fernández L, Pastor Gaitán P, Murillo Capitán E.
    Actas Urol Esp; 1989 Jan 23; 13(4):240-2. PubMed ID: 2678934
    [Abstract] [Full Text] [Related]

  • 17. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y, Yoshida K.
    Hinyokika Kiyo; 1999 Feb 23; 45(2):149-53. PubMed ID: 10212791
    [Abstract] [Full Text] [Related]

  • 18. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H, Tada Y, Nakano E, Matsuda M, Osafune M, Sagawa S, Takaha M, Sonoda T.
    Gan To Kagaku Ryoho; 1984 Aug 23; 11(8):1612-6. PubMed ID: 6541019
    [Abstract] [Full Text] [Related]

  • 19. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer.
    Hrushesky WJ, Roemeling RV, Wood PA, Langevin TR, Lange P, Fraley E.
    Cancer Treat Rep; 1987 Oct 23; 71(10):915-9. PubMed ID: 3652055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.